Works matching IS 20011326 AND DT 2025 AND VI 15 AND IP 4

Results: 38
    1

    Skeletal muscle effects of antisense oligonucleotides targeting glycogen synthase 1 in a mouse model of Pompe disease.

    Published in:
    Clinical & Translational Medicine, 2025, v. 15, n. 4, p. 1, doi. 10.1002/ctm2.70314
    By:
    • Weiss, Lan;
    • Carrer, Michele;
    • Shmara, Alyaa;
    • Martin, Angela;
    • Yin, Hong;
    • Pal, Pallabi;
    • Cheng, Cheng;
    • Ta, Lac;
    • Boock, Victoria;
    • Fazeli, Yasamin;
    • Chang, Mindy;
    • Paguio, Marvin;
    • Lee, Jonathan;
    • Yu, Howard;
    • Weiss, John;
    • Grossman, Tamar R;
    • Raben, Nina;
    • Jafar‐Nejad, Paymaan;
    • Kimonis, Virginia
    Publication type:
    Article
    2
    3
    4
    5
    6
    7
    8
    9
    10

    Response‐adapted zanubrutinib and tislelizumab as a potential strategy to enhance CD19 CAR T‐cell therapy in relapsed/refractory large B‐cell lymphoma: A retrospective observational study.

    Published in:
    Clinical & Translational Medicine, 2025, v. 15, n. 4, p. 1, doi. 10.1002/ctm2.70310
    By:
    • Shen, Rong;
    • Cao, Wei‐Guo;
    • Wang, Li;
    • Sheng, Ling‐Shuang;
    • Zhang, Yi‐Lun;
    • Wu, Wen;
    • Xu, Peng‐Peng;
    • Cheng, Shu;
    • Liu, Meng‐Ke;
    • Dong, Yan;
    • Wang, Yue;
    • Weng, Xiang‐Qin;
    • Jiang, Xu‐Feng;
    • Song, Qi;
    • Yi, Hong‐Mei;
    • Li, Lei;
    • Chen, Sheng;
    • Yan, Zi‐Xun;
    • Zhao, Wei‐Li
    Publication type:
    Article
    11
    12
    13
    14
    15
    16
    17
    18
    19
    20
    21
    22
    23
    24
    25

    Severe SARS‐CoV‐2 infection in diabetes was rescued in mice supplemented with metformin and/or αKG, and patients taking metformin, via HIF1α‐IFN axis.

    Published in:
    Clinical & Translational Medicine, 2025, v. 15, n. 4, p. 1, doi. 10.1002/ctm2.70275
    By:
    • Joshi, Garima;
    • Verma, Garima;
    • Kaur, Simrandeep;
    • Ramasamy, Ellango;
    • Chauhan, Navya;
    • Singh, Savita;
    • Jana, Pradipta;
    • Rizvi, Zaigham Abbas;
    • Kshetrapal, Pallavi;
    • Bhatnagar, Shinjini;
    • Pandey, Anil Kumar;
    • Awasthi, Amit;
    • Das, Bhabatosh;
    • Guchhait, Prasenjit
    Publication type:
    Article
    26

    BORA overexpression promotes epithelial–mesenchymal transition and metastasis in ovarian cancer: Unveiling a novel therapeutic target for advanced disease.

    Published in:
    Clinical & Translational Medicine, 2025, v. 15, n. 4, p. 1, doi. 10.1002/ctm2.70285
    By:
    • Barber, Marta;
    • Boloix, Ariadna;
    • Parrilla, Alfonso;
    • Köber, Mariana;
    • Avilés‐Domínguez, Laia;
    • Ventosa, Nora;
    • Ramírez‐Morales, Lidia del Carmen;
    • Perez‐Benavente, Asunción;
    • Gil‐Moreno, Antonio;
    • Colàs, Eva;
    • Morote, Juan;
    • Segura, Miguel F.;
    • Méndez, Olga;
    • Santamaria, Anna
    Publication type:
    Article
    27
    28
    29
    30
    31

    Sendotypes predict worsening renal function in chronic kidney disease patients.

    Published in:
    Clinical & Translational Medicine, 2025, v. 15, n. 4, p. 1, doi. 10.1002/ctm2.70279
    By:
    • McLarnon, Thomas;
    • Watterson, Steven;
    • McCallion, Sean;
    • Cooper, Eamonn;
    • English, Andrew R.;
    • Kuan, Ying;
    • Gibson, David S.;
    • Murray, Elaine K.;
    • McCarroll, Frank;
    • Zhang, Shu‐Dong;
    • Bjourson, Anthony J.;
    • Rai, Taranjit Singh
    Publication type:
    Article
    32

    Spatial omics strategies for investigating human carotid atherosclerotic disease.

    Published in:
    Clinical & Translational Medicine, 2025, v. 15, n. 4, p. 1, doi. 10.1002/ctm2.70277
    By:
    • Wan, Jiaxin;
    • Sun, Zhi;
    • Feng, Xueqiong;
    • Zhou, Peipei;
    • Macho, Mateus T. N.;
    • Jiao, Zhouyang;
    • Cao, Hui;
    • Zhang, Chuang;
    • Lin, Rijin;
    • Zhang, Xiaowen;
    • Fan, Mengyan;
    • Zhang, Nan;
    • Zhang, Jiamei;
    • Liu, Huixiang;
    • Li, Jing;
    • Guan, Sheng
    Publication type:
    Article
    33
    34
    35

    SETD2 loss of function is a recurrent event in advanced‐phase chronic myeloid leukemia and contributes to genomic instability: SETD2 loss in Chronic Myeloid Leukemia.

    Published in:
    Clinical & Translational Medicine, 2025, v. 15, n. 4, p. 1, doi. 10.1002/ctm2.70163
    By:
    • Mancini, Manuela;
    • De Santis, Sara;
    • Monaldi, Cecilia;
    • Castagnetti, Fausto;
    • Iezza, Miriam;
    • Iurlo, Alessandra;
    • Cattaneo, Daniele;
    • Galimberti, Sara;
    • Cerrano, Marco;
    • Capodanno, Isabella;
    • Bonifacio, Massimiliano;
    • Rossi, Maura;
    • Agostinelli, Claudio;
    • Meggendorfer, Manja;
    • Haferlach, Torsten;
    • Cavo, Michele;
    • Gugliotta, Gabriele;
    • Soverini, Simona
    Publication type:
    Article
    36

    Transitional CXCL14<sup>+</sup> cancer‐associated fibroblasts enhance tumour metastasis and confer resistance to EGFR‐TKIs, revealing therapeutic vulnerability to filgotinib in lung adenocarcinoma.

    Published in:
    Clinical & Translational Medicine, 2025, v. 15, n. 4, p. 1, doi. 10.1002/ctm2.70281
    By:
    • Xu, Weijiao;
    • Yang, Haitang;
    • Xu, Ke;
    • Zhu, Anshun;
    • Hall, Sean R. R.;
    • Jia, Yunxuan;
    • Zhao, Baicheng;
    • Zhang, Enshuo;
    • Liu, Gang;
    • Xu, Jianlin;
    • Marti, Thomas M.;
    • Peng, Ren‐Wang;
    • Dorn, Patrick;
    • Niu, Yongliang;
    • Pan, Xufeng;
    • Zhang, Yajuan;
    • Yao, Feng
    Publication type:
    Article
    37
    38